IL4I1 Is a Metabolic Immune Checkpoint that Activates the AHR and Promotes Tumor Progression

Clicks: 179
ID: 117825
2020
Free PDF
Article Quality & Performance Metrics
Overall Quality Improving Quality
0.0 /100
Combines engagement data with AI-assessed academic quality
AI Quality Assessment
Not analyzed
Abstract
Aryl hydrocarbon receptor (AHR) activation by tryptophan (Trp) catabolites enhances tumor malignancy and suppresses anti-tumor immunity. The context specificity of AHR target genes has so far impeded systematic investigation of AHR activity and its upstream enzymes across human cancers. A pan-tissue …
Reference Key
a2020cellil4i1 Use this key to autocite in the manuscript while using SciMatic Manuscript Manager or Thesis Manager
Authors Sadik A;Somarribas Patterson LF;Öztürk S;Mohapatra SR;Panitz V;Secker PF;Pfänder P;Loth S;Salem H;Prentzell MT;Berdel B;Iskar M;Faessler E;Reuter F;Kirst I;Kalter V;Foerster KI;Jäger E;Guevara CR;Sobeh M;Hielscher T;Poschet G;Reinhardt A;Hassel JC;Zapatka M;Hahn U;von Deimling A;Hopf C;Schlichting R;Escher BI;Burhenne J;Haefeli WE;Ishaque N;Böhme A;Schäuble S;Thedieck K;Trump S;Seiffert M;Opitz CA;;
Journal Cell
Year 2020
DOI
DOI not found
URL
https://www.pubmed.gov/32818467/
Keywords
National Center for Biotechnology Information NCBI NLM MEDLINE pubmed abstract nih national institutes of health national library of medicine pmid:32818467 doi:10.1016/j.cell.2020.07.038 ahmed sadik luis f somarribas patterson christiane a opitz

Citations

No citations found. To add a citation, contact the admin at info@scimatic.org

Comments

No comments yet. Be the first to comment on this article.